Comment
. 2005 Oct;10(9):762-3; author reply 764-5.
doi: 10.1634/theoncologist.10-9-762.
Response to "effect of patient exclusion criteria on the efficacy of erythropoiesis-stimulating agents in patients with cancer-related anemia"
- PMID: 16249359
- DOI: 10.1634/theoncologist.10-9-762
Item in Clipboard
Comment
Response to "effect of patient exclusion criteria on the efficacy of erythropoiesis-stimulating agents in patients with cancer-related anemia"
Oncologist.
2005 Oct.
Free article
No abstract available
Comment on
-
Effect of patient exclusion criteria on the efficacy of erythropoiesis-stimulating agents in patients with cancer-related anemia.Oncologist. 2005 May;10(5):357-60. doi: 10.1634/theoncologist.10-5-357. Oncologist. 2005. PMID: 15851794 Review.
Similar articles
-
Warning flags for erythropoiesis-stimulating agents and cancer-associated anemia.Oncologist. 2007 Apr;12(4):362-5. doi: 10.1634/theoncologist.12-4-362. Oncologist. 2007. PMID: 17470677 No abstract available.
-
New ASH/ASCO guidelines on the use of erythropoiesis-stimulating agents: a chorale amid cacophony.J Support Oncol. 2007 Nov-Dec;5(10):471-3. J Support Oncol. 2007. PMID: 18240668 No abstract available.
-
[Current issues in erythropoietin therapy of renal anemia].Lege Artis Med. 2007 Oct;17(10):667-73. Lege Artis Med. 2007. PMID: 19227596 Review. Hungarian.
-
Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.Strahlenther Onkol. 2008 Mar;184(3):121-36. doi: 10.1007/s00066-008-1841-3. Strahlenther Onkol. 2008. PMID: 18330508 Review.
-
Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia.JAMA. 2008 Dec 24;300(24):2854-5; author reply 2855-7. doi: 10.1001/jama.2008.868. JAMA. 2008. PMID: 19109112 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
